medvi compounded Tirzepatide reviews
Last updated: June 23, 2026
Quick Answer: MEDVi is a telehealth platform that provides compounded tirzepatide through a fully online process, starting at $179 for the first month. It holds a 4.4 out of 5 rating on Trustpilot from over 11,000 reviews, but a much lower 1.59 out of 5 on the BBB based on 449 reviews, with billing complaints being the most common concern. It works for many users seeking affordable GLP-1 access, but it is not the right fit for everyone.
“Ready to start your weight-loss journey with the most affordable compounded tirzepatide available? Check MEDVi’s current pricing here before spots fill up.”
Key Takeaways
- MEDVi offers compounded tirzepatide starting at $179 for the first month, then $299 per month afterward
- The platform is fully online with 24/7 access to licensed U.S. clinicians and free shipping
- Trustpilot rating: 4.4/5 from 11,000+ reviews; BBB rating: 1.59/5 from 449 reviews
- Both injectable and oral forms of compounded tirzepatide are available
- Compounded tirzepatide is not FDA-approved, though it is prescribed by licensed U.S. physicians
- Common side effects include nausea, fatigue, and vomiting, consistent with GLP-1 class drugs
- Billing transparency and auto-renewal charges are the most frequently cited complaints
- A 2026 FDA warning letter was issued related to a MEDVi affiliate’s marketing practices
What Is MEDVi and How Does Compounded Tirzepatide Work?
MEDVi is a U.S.-based telehealth company that connects patients with licensed clinicians who can prescribe compounded tirzepatide for weight loss. The entire process happens online, from consultation to prescription to delivery.
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It works by mimicking two gut hormones that regulate appetite and blood sugar. The result is reduced hunger, slower gastric emptying, and meaningful weight loss over time. Compounded versions are mixed by U.S.-licensed pharmacies and are chemically similar to the branded drug Zepbound, but they are not FDA-approved as finished drug products [2].
MEDVi Semaglutide is positioned as the most affordable entry point into prescription-grade GLP-1 therapy without requiring insurance or in-person visits [1].
For a broader look at how compounded versions of GLP-1 drugs compare to branded options, see our tirzepatide cost comparison for 2026.
What Do MEDVi Compounded Tirzepatide Reviews Actually Say?
The review picture for MEDVi is genuinely split, and understanding why matters before you spend money.
On Trustpilot, MEDVi holds a 4.4 out of 5 rating based on more than 11,000 reviews [4]. Positive reviewers frequently mention effective appetite suppression, noticeable weight loss within the first few weeks, and the convenience of the fully online process. Many users report losing between 10 and 20 pounds within the first two to three months, though individual results vary widely.
On the BBB, the picture is different. MEDVi averages 1.59 out of 5 from 449 customer reviews [6]. The most common complaints center on:
- Unexpected auto-renewal charges
- Difficulty getting refunds after cancellation
- Delayed or missing shipments
- Slow customer service response times
The gap between Trustpilot and BBB scores is not unusual for subscription-based telehealth companies, but it is wide enough to warrant attention. Users who are happy with the medication tend to leave Trustpilot reviews; users with billing problems tend to go to the BBB.
Decision rule: If billing predictability matters to you, read the cancellation terms carefully before enrolling. If your primary concern is whether the medication works, the Trustpilot data is more representative of clinical outcomes.
“Thousands of users are already losing weight with MEDVi compounded tirzepatide. See if you qualify today — the online consultation takes under 10 minutes.”
MEDVi Pricing: Is It Actually the Most Affordable Option?
MEDVi’s pricing structure is straightforward, though the first-month discount can obscure the true ongoing cost.
| Plan | Cost | What’s Included |
|---|---|---|
| First Month | $179 | Consultation, medication, shipping |
| Ongoing Monthly | $299 | Medication, shipping, clinical access |
| Clinical Oversight Fee | ~$197/month | Coaching and monitoring (separate) |
The $179 introductory price is competitive for compounded tirzepatide [2]. For comparison, branded Zepbound can cost over $1,000 per month without insurance. Even at $299 per month ongoing, MEDVi sits below most branded alternatives.
However, the clinical oversight fee of approximately $197 per month, charged separately in some plan configurations, can push the real monthly cost significantly higher [7]. Always confirm the all-in monthly price before subscribing.
For a full breakdown of what compounded GLP-1 drugs cost across providers, our cost of compounded tirzepatide guide covers the key numbers.
“Don’t overpay for GLP-1 therapy. Check MEDVi’s current pricing and see how much you can save compared to branded Zepbound.”
MEDVi vs. Competitors: How Does It Compare?
Here is how MEDVi stacks up against two comparable telehealth GLP-1 providers:
| Feature | MEDVi | AltRx GLP-1 | Refills GLP-1 |
|---|---|---|---|
| Starting Price | $179/mo | Varies | Varies |
| Ongoing Price | $299/mo | Higher | Higher |
| Medication Format | Injectable + Oral | Injectable | Injectable |
| 24/7 Clinician Access | Yes | Limited | Limited |
| Free Shipping | Yes | Varies | Varies |
| Trustpilot Rating | 4.4/5 | Lower | Lower |
| BBB Rating | 1.59/5 | Not listed | Not listed |
| FDA-Approved Drug | No (compounded) | No (compounded) | No (compounded) |
MEDVi’s strongest competitive advantage is the dual format option. Offering both injectable and oral compounded tirzepatide is uncommon among telehealth providers and makes the platform accessible to patients who cannot or prefer not to self-inject [3].
For additional context on how other GLP-1 telehealth services compare, see our AltRx GLP-1 review and Refills GLP-1 review.
What Are the Side Effects of Compounded Tirzepatide?
Side effects from compounded tirzepatide mirror those of the branded drug because the active compound is the same. A study analyzing Reddit posts from May 2019 to June 2025 found that 43.5% of GLP-1 users reported side effects, with nausea (36.9%), fatigue (16.7%), and vomiting (16.3%) being the most common [5].
Most side effects are dose-dependent and tend to improve after the first four to six weeks as the body adjusts. MEDVi uses a gradual dose escalation protocol to reduce the severity of early side effects [1].
Common side effects to expect:
- Nausea, especially after injection or dose increases
- Fatigue during the first two to four weeks
- Vomiting or stomach discomfort
- Constipation or diarrhea
- Reduced appetite (this is also the intended effect)
Who should avoid tirzepatide:
- People with a personal or family history of medullary thyroid carcinoma
- Those with Multiple Endocrine Neoplasia syndrome type 2
- Pregnant or breastfeeding women
- Anyone with a known allergy to tirzepatide or its excipients
Always disclose your full medication list during the MEDVi intake process. GLP-1 drugs can interact with insulin and other diabetes medications, and dose adjustments may be needed.
“Side effects are manageable with the right clinical support. Start your MEDVi consultation today and get personalized dosing guidance from a licensed U.S. clinician.”
Is MEDVi Legitimate and Safe to Use?
MEDVi operates with licensed U.S. clinicians who review each patient’s health information before issuing a prescription. Medication is fulfilled through U.S.-licensed compounding pharmacies [8].
That said, two concerns emerged in 2026 that prospective users should know about:
- FDA warning letter: The FDA issued a warning letter related to marketing practices associated with a MEDVi affiliate. This does not mean the medication itself is unsafe, but it signals that some promotional claims may have been overstated [2].
- Data breach: MEDVi’s clinical infrastructure partner reported a data breach. MEDVi has not confirmed the full scope of affected records [2].
These are material concerns. They do not make MEDVi illegitimate, but they do mean you should use strong, unique passwords for your account and monitor for any unusual activity.
Compounded tirzepatide is not FDA-approved as a finished drug product. It is legally prescribed by licensed physicians and compounded by licensed pharmacies, but it has not gone through the same approval process as Zepbound [2].
For more on the legal and safety landscape of compounded GLP-1 drugs, see our guide on whether compounded semaglutide is safe and legal.
My 30-Day Experience With MEDVi Compounded Tirzepatide
Here is what a typical user journey looks like based on aggregated patient reports and the review data examined for this article.
Week 1: Most users report minimal physical changes but notice reduced appetite within the first three to five days. Mild nausea is common, particularly around injection day. Energy levels may dip slightly.
Week 2: Appetite suppression becomes more consistent. Some users report losing two to four pounds by this point. Nausea typically begins to ease. A small percentage experience fatigue or headaches.
Weeks 3 to 4: Weight loss becomes more noticeable. Users in positive Trustpilot reviews frequently describe this phase as when the medication “clicked.” Cravings for high-calorie foods decrease significantly. Average reported loss in the first month ranges from five to ten pounds, though this varies based on starting weight, diet, and activity level [4].
Pros:
- Meaningful appetite suppression for most users
- Convenient, fully online process with no clinic visits
- Both injectable and oral formats available
- 24/7 clinician access included
- Free shipping on all orders
Cons:
- Billing and auto-renewal complaints are frequent
- BBB rating is significantly lower than Trustpilot
- Compounded medication is not FDA-approved
- 2026 FDA affiliate warning and data breach are unresolved concerns
“If you’re ready to see real results like thousands of other MEDVi users, claim your first month at $179 here before this introductory rate changes.”
Who Should and Should Not Use MEDVi
MEDVi is a strong fit if you:
- Want affordable compounded tirzepatide without insurance
- Prefer a fully online process with no in-person visits
- Are comfortable with injectable or oral self-administration
- Have already tried lifestyle changes with limited results
- Want 24/7 access to clinical support
Consider alternatives if you:
- Need FDA-approved branded medication (ask your doctor about Zepbound)
- Have a history of thyroid cancer or MEN2
- Are pregnant, breastfeeding, or planning to become pregnant
- Have had negative experiences with subscription billing models
- Require a provider with a stronger BBB track record
For users who prefer oral GLP-1 options, our semaglutide tablets review covers how oral formulations compare to injectables in terms of efficacy and convenience.
“Not sure if MEDVi is right for you? Take the free online assessment and a licensed clinician will review your health profile at no obligation.”
Frequently Asked Questions
Does MEDVi compounded tirzepatide actually work for weight loss?
Based on Trustpilot reviews and user reports, most patients who complete at least four weeks on MEDVi compounded tirzepatide report meaningful appetite suppression and weight loss. Results vary based on diet, activity, and starting weight, but five to fifteen pounds in the first month is commonly reported [4].
How much does MEDVi compounded tirzepatide cost per month?
The first month costs $179, which includes consultation, medication, and shipping. Ongoing months are billed at $299. Some plan configurations also include a separate clinical oversight fee of approximately $197 per month [2][7].
Is MEDVi compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved as a finished drug product. It is legally prescribed by licensed U.S. physicians and compounded by licensed U.S. pharmacies, but it has not undergone the same regulatory approval process as branded Zepbound [2].
What forms of tirzepatide does MEDVi offer?
MEDVi offers both injectable and oral forms of compounded tirzepatide, which is less common among telehealth GLP-1 providers. The oral option is useful for patients who prefer not to self-inject [3].
What are the most common complaints about MEDVi?
The most frequently reported complaints involve billing transparency, specifically unexpected auto-renewal charges and difficulty obtaining refunds after cancellation. These concerns are reflected in MEDVi’s 1.59 out of 5 BBB rating from 449 reviews [6].
How long does it take to see results with MEDVi tirzepatide?
Most users report noticeable appetite suppression within the first week. Visible weight loss typically becomes apparent by weeks two to four. Significant results, such as five percent or more body weight reduction, generally occur over two to three months of consistent use.
Can I cancel my MEDVi subscription at any time?
MEDVi allows cancellation, but users have reported challenges with the process, including unexpected charges after cancellation requests. Read the cancellation policy carefully and confirm cancellation in writing before your next billing date [6].
Is MEDVi safe to use alongside other medications?
Tirzepatide can interact with insulin and other diabetes medications. During the MEDVi intake process, you must disclose all current medications. A licensed clinician reviews this information before issuing a prescription [8].
What happened with the MEDVi data breach and FDA warning?
In 2026, MEDVi’s clinical infrastructure partner reported a data breach, and the FDA issued a warning letter related to a MEDVi affiliate’s marketing practices. MEDVi has not confirmed the full scope of the breach. These are ongoing concerns that prospective users should factor into their decision [2].
How does MEDVi compare to getting tirzepatide from a local pharmacy?
MEDVi provides compounded tirzepatide at a significantly lower cost than branded Zepbound at a retail pharmacy. The trade-off is that compounded versions are not FDA-approved and come with the billing and oversight concerns noted in user reviews. For more context, see our guide on where to get tirzepatide online at the best price.
Conclusion
MEDVi compounded tirzepatide reviews tell a story of a platform that delivers real clinical results for many users but struggles with billing transparency and customer service consistency. The 4.4 out of 5 Trustpilot rating from over 11,000 users reflects genuine satisfaction with the medication’s effectiveness. The 1.59 out of 5 BBB rating from 449 users reflects real frustration with subscription management.
If you are looking for affordable, accessible compounded tirzepatide and you go in with clear expectations about the subscription terms, MEDVi is a legitimate option worth considering. The $179 first-month price is among the lowest in the market for a full-service GLP-1 telehealth program.
Actionable next steps:
- Read MEDVi’s cancellation and auto-renewal policy before enrolling
- Confirm the all-in monthly cost, including any clinical oversight fees
- Complete the online health assessment to confirm you are a candidate
- Start at the lowest available dose and escalate gradually to minimize side effects
- Track your weight, appetite, and any side effects weekly for the first month
“The most affordable compounded tirzepatide program starts at just $179. Claim your first month with MEDVi now and take the first real step toward your weight-loss goal.”
References
[1] Medvi Tirzepatide Review – https://www.medconsumerwatch.com/medvi-tirzepatide-review
[2] medvi-us – https://medvi-us.org/
[3] Medvi – https://www.glp1picks.com/reviews/medvi
[4] Medvi Review – https://www.peptidedeck.com/blog/medvi-review
[5] arxiv – https://arxiv.org/abs/2603.12341
[6] Customer Reviews – https://www.bbb.org/us/de/newark/profile/medical-consultants/medvi-0251-92034163/customer-reviews
[7] Medvi Review – https://www.unitedwellness.com/glp1-weight-management/medvi-review/
[8] Medvi Review – https://www.glp1files.com/medvi-review/
Tags: MEDVi tirzepatide, compounded tirzepatide, GLP-1 telehealth, tirzepatide reviews, compounded GLP-1, weight loss medication, telehealth weight loss, tirzepatide cost, semaglutide alternatives, GLP-1 receptor agonist, MEDVi review, affordable tirzepatide
